Metagen Therapeutics

About Metagen Therapeutics

Metagen Therapeutics, Inc. is a company focused on advancing medical services and drug discovery based on gut microbiota research. Their mission is to deliver microbiome-based medical treatments to patients as quickly as possible, with a vision to fulfill patients' wishes through microbiome science.

Products & Services

FMT Platform:A platform centered on Fecal Microbiota Transplantation (FMT) to provide medical services and support drug discovery initiatives for patients.

Medical Services:Services utilizing microbiome science to offer innovative medical treatments.

Drug Discovery:Drug development initiatives based on FMT and microbiome science to create groundbreaking pharmaceuticals.

Specialties

Gut Microbiota Research Fecal Microbiota Transplantation (FMT) Microbiome Science Drug Discovery Medical Services

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 1700000000 MR: - FA: 1.7 billion yen FAN: 1700000000	D: 2023-06-15 FD: 2023-06-15	8 investors

Series A Latest

2023-06-15

$1.7B

8 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

T

Taku Nakahara

Chief Executive Officer

D

Dai Ishikawa

Chief Medical Officer

J

Jun Terauchi

Chief Scientific Officer

H

HIROTO TAMURA

Chief Operating Officer

T

Takashi Nishino

Chief Financial Officer

S

Shinji Fukuda

Senior Scientific Advisor

View 11 more team members with Pro

Unlock Full Team Directory

Recent News